Furthermore, we explored the KM Plotter Database and found that patients with high-expression of NR4A3 had significantly better OS, RFS, and DMFS than those with low expression of NR4A3 (Fig. 6d–f), suggesting that NR4A3 expression inhibits metastasis and progression of BC in these patients. Here, NR4A3 is linked to breast cancer.